Decision Support Interventions (DESI) for Prostate Cancer Screening - Study 1



Status:Archived
Conditions:Prostate Cancer, Healthy Studies
Therapuetic Areas:Oncology, Other
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:January 2011
End Date:November 2013

Use our guide to learn which trials are right for you!

Acceleration Adoption of Comparative Effectiveness Research Results With Patient Decision Support Intervention and Treatment (DESI)- Study 1


In this study we will compare 3 strategies for systematic delivery of prostate cancer
screening decision support interventions (DESI) to usual care and examine their impact on
screening decisions and subsequent healthcare utilization using a randomized control design.

We hypothesize men who are given the opportunity to review a DESI by one of the 3 strategies
will be less likely to opt for prostate cancer screening, and will have lower subsequent
healthcare utilization than men in the control group.


We will use a randomized experimental design to compare the effects of 3 different
strategies to implement a prostate cancer screening decision support intervention (DESI)
with a control condition in primary care in 2 clinical systems - PAMF (Palo Alto Medical
Foundation) and UNC. The primary outcomes of interest are men's screening decisions and
their subsequent healthcare utilization. Secondary outcomes include the likelihood that
they review the DESI and their decision-specific knowledge. The 3 strategies selected by the
PAMF and UNC health systems are: (1) mailing men a DESI in DVD; (2) inviting men to
participate in a shared (group) medical appointment (SMA) to watch and discuss the DESI with
a healthcare provider and other men; and (3) providing men options by inviting them to a SMA
while also providing them a DESI in DVD which they can use individually if they are unable
or choose not to attend a SMA. The 3 groups will be compared to a control condition that
does not receive a DESI but will be encouraged to discuss prostate cancer screening with
their physician. Because of its significantly larger patient population, the PAMF site will
also evaluate these outcomes by targeting screening-naïve patients on their 50th birthday,
when they first become guideline eligible to consider prostate cancer screening.


We found this trial at
2
sites
101 Manning Dr
Chapel Hill, North Carolina 27599
(919) 966-4131
University of North Carolina Hospital at Chapel Hill The UNC Health Care System is a...
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
?
mi
from
Palo Alto, CA
Click here to add this to my saved trials